{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:55:51Z","timestamp":1790463351998,"version":"4.1.0"},"reference-count":85,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5551\/jat.31617","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T22:02:35Z","timestamp":1437429755000},"page":"1001-1011","source":"Crossref","is-referenced-by-count":91,"title":["Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism"],"prefix":"10.5551","volume":"22","author":[{"given":"Junji","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Kanazawa Medical University General Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Immuno-Biological Laboratories Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Kanazawa University Graduate School of Pharmaceutical Health Sciences, lipid research course"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kirchgessner TG, Chuat JC, Heinzmann C, Etienne J, Guilhot S, Svenson K, Ameis D, Pilon C, d'Auriol L, Andalibi A, et al: Organization of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc Natl Acad Sci U S A, 1989; 86: 9647-9651","DOI":"10.1073\/pnas.86.24.9647"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Choi SY, Hirata K, Ishida T, Quertermous T, Cooper AD: Endothelial lipase: a new lipase on the block. J Lipid Res, 2002; 43: 1763-1769","DOI":"10.1194\/jlr.R200011-JLR200"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cai S, Wong DM, Chen SH, Chan L: Structure of the human hepatic triglyceride lipase gene. Biochemistry, 1989; 28: 8966-8971","DOI":"10.1021\/bi00449a002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, B\u00fcscher M, Schotz MC, Will H: Isolation and characterization of the human hepatic lipase gene. J Biol Chem, 1990; 265: 6552-6555","DOI":"10.1016\/S0021-9258(19)39182-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Warden CH1, Davis RC, Yoon MY, Hui DY, Svenson K, Xia YR, Diep A, He KY, Lusis AJ: Chromosomal localization of lipolytic enzymes in the mouse: pancreatic lipase, colipase, hormone-sensitive lipase, hepatic lipase, and carboxyl ester lipase. J Lipid Res, 1993; 34: 1451-1455","DOI":"10.1016\/S0022-2275(20)36974-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Santamarina-Fojo S, Gonz\u00e1lez-Navarro H, Freeman L, Wagner E, Nong Z: Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol, 2004; 24: 1750-1754","DOI":"10.1161\/01.ATV.0000140818.00570.2d"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Davis RC, Stahnke G, Wong H, Doolittle MH, Ameis D, Will H, Schotz MC: Hepatic lipase: site-directed mutagenesis of a serine residue important for catalytic activity. J Biol Chem, 1990; 265: 6291-6295","DOI":"10.1016\/S0021-9258(19)39324-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dugi KA, Dichek HL, Santamarina-Fojo S: Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity. J Biol Chem, 1995; 270: 25396-25401","DOI":"10.1074\/jbc.270.43.25396"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kobayashi J, Applebaum-Bowden D, Dugi KA, Brown DR, Kashyap VS, Parrott C, Duarte C, Maeda N, Santamarina-Fojo S: Analysis of protein structure-function in vivo. Adenovirus-mediated transfer of lipase lid mutants in hepatic lipase-deficient mice. J Biol Chem, 1996; 271: 26296-26301","DOI":"10.1074\/jbc.271.42.26296"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Davis RC, Wong H, Nikazy J, Wang K, Han Q, Schotz MC: Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties. J Biol Chem, 1992; 267: 21499-21504","DOI":"10.1016\/S0021-9258(19)36637-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Dichek HL, Parrott C, Ronan R, Brunzell JD, Brewer HB Jr, Santamarina-Fojo S: Functional characterization of a chimeric lipase genetically engineered from human lipoprotein lipase and human hepatic lipase. J Lipid Res, 1993; 34: 1393-1340","DOI":"10.1016\/S0022-2275(20)36968-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sultan F, Lagrange D, Jansen H, Griglio S: Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim Biophys Acta, 1990; 1042: 150-152","DOI":"10.1016\/0005-2760(90)90071-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Diard P, Malewiak MI, Lagrange D, Griglio S: Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem J, 1994; 299: 889-894","DOI":"10.1042\/bj2990889"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW: Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem, 1994; 269: 13429-13436","DOI":"10.1016\/S0021-9258(17)36850-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) de Faria E, Fong LG, Komaromy M, Cooper AD: Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J Lipid Res, 1996; 37: 197-209","DOI":"10.1016\/S0022-2275(20)37648-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Homanics GE, de Silva HV, Osada J, Zhang SH, Wong H, Borensztajn J, Maeda N: Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem, 1995; 270: 2974-2980","DOI":"10.1074\/jbc.270.7.2974"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Applebaum-Bowden D, Kobayashi J, Kashyap VS, Brown DR, Berard A, Meyn S, Parrott C, Maeda N, Shamburek R, Brewer HB Jr, Santamarina-Fojo S: Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirusmediated replacement of a lipolytic enzyme to the vascular endothelium. J Clin Invest, 1996; 97: 799-805","DOI":"10.1172\/JCI118479"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Braschi S1, Couture N, Gambarotta A, Gauthier BR, Coffill CR, Sparks DL, Maeda N, Schultz JR: Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse. Biochim Biophys Acta, 1998; 1392: 276-290","DOI":"10.1016\/S0005-2760(98)00046-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Dichek HL, Brecht W, Fan J, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley RW: Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J Biol Chem, 1998; 273: 1896-1903","DOI":"10.1074\/jbc.273.4.1896"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Amar MJ, Dugi KA, Haudenschild CC, Shamburek RD, Foger B, Chase M, Bensadoun A, Hoyt RF Jr, Brewer HB Jr, Santamarina-Fojo S: Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice. J Lipid Res, 1998; 39: 2436-2442","DOI":"10.1016\/S0022-2275(20)33323-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM: Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A, 1994; 91: 8724-8728","DOI":"10.1073\/pnas.91.18.8724"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sanan DA, Fan J, Bensadoun A, Taylor JM: Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res, 1997; 38: 1002-1013","DOI":"10.1016\/S0022-2275(20)37224-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Barbagallo CM, Fan J, Blanche PJ, Rizzo M, Taylor JM, Krauss RM: Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler Thromb Vasc Biol, 1999; 19: 625-632","DOI":"10.1161\/01.ATV.19.3.625"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Carr MC, Ayyobi AF, Murdoch SJ, Deeb SS, Brunzell JD: Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler Thromb Vasc Biol, 2002; 22: 667-673","DOI":"10.1161\/01.ATV.0000013284.47317.95"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Imamura S, Kobayashi J, Sakasegawa S, Nohara A, Nakajima K, Kawashiri M, Inazu A, Yamagishi M, Koizumi J, Mabuchi H: A novel method for measuring human hepatic lipase activity in postheparin plasma. J Lipid Res, 2007; 48: 453-457","DOI":"10.1194\/jlr.D600022-JLR200"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Imamura S, Kobayashi J, Nakajima K, Sakasegawa S, Nohara A, Noguchi T, Kawashiri MA, Inazu A, Deeb SS, Mabuchi H, Brunzell JD: A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma. J Lipid Res, 2008; 49: 1431-1437","DOI":"10.1194\/jlr.M700528-JLR200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nakajima K, Kobayashi J, Mabuchi H, Nakano T, Tokita Y, Nagamine T, Imamura S, Ai M, Otokozawa S, Schaefer EF: Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Ann Clin Biochem, 2010; 47: 423-431","DOI":"10.1258\/acb.2010.009307"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Huff MW, Sawyez CG, Connelly PW, Maguire GF, Little JA, Hegele RA: Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages. Arterioscler Thromb, 1993; 13: 1282-1290","DOI":"10.1161\/01.ATV.13.9.1282"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Connelly PW, Hegele RA: Hepatic lipase deficiency. Crit Rev Clin Lab Sci, 1998; 35: 547-572","DOI":"10.1080\/10408369891234273"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Connelly PW: The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta, 1999; 286: 243-255","DOI":"10.1016\/S0009-8981(99)00105-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Mezdour H, Jones R, Dengremont C, Castro G, Maeda N: Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem, 1997; 272: 13570-13575","DOI":"10.1074\/jbc.272.21.13570"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW: Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb, 1993; 13: 720-728","DOI":"10.1161\/01.ATV.13.5.720"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Knudsen P, Antikainen M, Uusi-Oukari M, Ehnholm S, Lahdenper\u00e4 S, Bensadoun A, Funke H, Wiebusch H, Ass mann G, Taskinen MR, Ehnholm C: Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis, 1997; 128: 165-174","DOI":"10.1016\/S0021-9150(96)05999-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Miyashita K, Kobayashi J, Imamura S, Kinoshita N, Stanhope KL, Havel PJ, Nakajima K, Machida T, Sumino H, Nara M, Murakami M: A new enzyme-linked immunosorbent assay system for human hepatic triglyceride lipase. Clin Chim Acta, 2013; 424: 201-206","DOI":"10.1016\/j.cca.2013.06.016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Jansen H, Verhoeven AJM, Weeks L, Kastelein JJP, Halley DJJ, Van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC: Common C-to-T substitution at position 2480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol, 1997; 17: 2837-2842","DOI":"10.1161\/01.ATV.17.11.2837"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Murtomaki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, Ehnholm C: Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. Arterioscler Thromb Vasc Biol, 1997; 17: 1879-1884","DOI":"10.1161\/01.ATV.17.10.1879"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Zambon A, Deeb SS, Hokanson JE, Greg Brown B, Brunzell JD: Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol, 1998; 18: 1723-1729","DOI":"10.1161\/01.ATV.18.11.1723"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PWF, Schaefer EJ, Ordovas JM: Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol, 2000; 20: 815-822","DOI":"10.1161\/01.ATV.20.3.815"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, Kauma H, Pasternak A, Taskinen MR, Ehnholm C: Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest, 1998; 101: 956-960","DOI":"10.1172\/JCI1144"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Inazu A, Nishimura Y, Terada Y, Mabuchi H: Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population. J Hum Genet, 2001; 46: 172-177","DOI":"10.1007\/s100380170084"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42) Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC: Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol, 1999; 19: 1975-1978","DOI":"10.1161\/01.ATV.19.8.1975"},{"key":"42","doi-asserted-by":"crossref","unstructured":"44) Sorva R1, Kuusi T, Taskinen MR, Perheentupa J, Nikkil\u00e4 EA: Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hydrogonadal males. Atherosclerosis, 1988; 69: 191-197","DOI":"10.1016\/0021-9150(88)90014-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"45) Tikkanen MJ, Nikkil\u00e4 EA, Kuusi T, Sipinen SU: High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by oestrogens and norgestrel. J Clin Endocrinol Metab, 1982; 54: 1113-1117","DOI":"10.1210\/jcem-54-6-1113"},{"key":"44","doi-asserted-by":"crossref","unstructured":"46) Schoonderwoerd K, H\u00fclsmann WC, Jansen H: Regulation of liver lipase. I. Evidence for several regulatory sites, studied in corticotrophin-treated rats. Biochim Biophys Acta, 1983; 754: 279-283","DOI":"10.1016\/0005-2760(83)90143-1"},{"key":"45","doi-asserted-by":"crossref","unstructured":"47) Berg AL, Nilsson-Ehle P: Direct effects of corticotropin on plasma lipoprotein metabolism in man-studies in vivo and in vitro. Metabolism, 1994; 43: 90-97","DOI":"10.1016\/0026-0495(94)90162-7"},{"key":"46","doi-asserted-by":"crossref","unstructured":"48) Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P: Relations between thyroid function, hepatic ant lipopro tein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol, 1983; 104: 50-56","DOI":"10.1530\/acta.0.1040050"},{"key":"47","doi-asserted-by":"crossref","unstructured":"49) Kihara S, W\u00f6lle J, Ehnholm C, Chan L, Oka K: Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells. J Lipid Res, 1993; 34: 961-970","DOI":"10.1016\/S0022-2275(20)39682-6"},{"key":"48","doi-asserted-by":"crossref","unstructured":"50) Baynes C, Henderson AD, Anyaoku V, Richmond W, Hughes CL, Johnston DG, Elkeles RS: The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med, 1991; 8: 560-566","DOI":"10.1111\/j.1464-5491.1991.tb01652.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"51) Carr MC, Hokanson JE, Zambon A, Deeb SS, Barrett PH, Purnell JQ, Brunzell JD: The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low\/high density lipoprotein heterogeneity. J Clin Endocrinol Metab, 2001; 86: 2831-2837","DOI":"10.1210\/jc.86.6.2831"},{"key":"50","doi-asserted-by":"crossref","unstructured":"52) Reynisdottir S, Angelin B, Langin D, Lithell H, Eriksson M, Holm C, Arner P: Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome. Arterioscler Thromb Vasc Biol, 1997; 17: 2287-2292","DOI":"10.1161\/01.ATV.17.10.2287"},{"key":"51","doi-asserted-by":"crossref","unstructured":"53) Hanyu O, Miida T, Kosuge K, Ito T, Soda S, Hirayama S, Wardaningsih E, Fueki Y, Obayashi K, Aizawa Y: Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents. Clin Chim Acta, 2007; 384: 118-123","DOI":"10.1016\/j.cca.2007.06.015"},{"key":"52","doi-asserted-by":"crossref","unstructured":"54) Miyashita Y, Shirai K, Itoh Y, Sasaki H, Totsuka M, Murano T, Watanabe H: Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy. Diabetes Res Clin Pract, 2002; 56: 181-187","DOI":"10.1016\/S0168-8227(01)00369-2"},{"key":"53","doi-asserted-by":"crossref","unstructured":"55) Taskinen MR, Nikkil\u00e4 EA, Kuusi T, Harmo K: Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia, 1982; 22: 46-50","DOI":"10.1007\/BF00253869"},{"key":"54","doi-asserted-by":"crossref","unstructured":"56) Kobayashi J, Saito K, Fukamachi I, Taira K, Takahashi K, Bujo H, Saito Y: Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation. Horm Metab Res, 2001; 33: 412-416","DOI":"10.1055\/s-2001-16230"},{"key":"55","doi-asserted-by":"crossref","unstructured":"57) Kobayashi J, Tashiro J, Murano S, Morisaki N, Saito Y: Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation. Clin Endocrinol (Oxf), 1998; 48: 515-520","DOI":"10.1046\/j.1365-2265.1998.00485.x"},{"key":"56","doi-asserted-by":"crossref","unstructured":"58) Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, Murano T, Miyashita Y, Shirai K: Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract, 2007; 76: 93-101","DOI":"10.1016\/j.diabres.2006.08.004"},{"key":"57","doi-asserted-by":"crossref","unstructured":"59) Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K: Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol, 2003; 14: 561-566","DOI":"10.1097\/00041433-200312000-00003"},{"key":"58","doi-asserted-by":"crossref","unstructured":"60) Matsuzawa Y, Funahashi T, Nakamura T: The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb, 2011; 18: 629-639","DOI":"10.5551\/jat.7922"},{"key":"59","doi-asserted-by":"crossref","unstructured":"61) Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I: Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb, 2010; 17: 1201-1211","DOI":"10.5551\/jat.6106"},{"key":"60","doi-asserted-by":"crossref","unstructured":"62) Kobayashi J, Kusunoki M, Murase Y, Kawashiri M, Higashikata T, Miwa K, Katsuda S, Takata M, Asano A, Nohara A, Inazu A, Mabuchi H: Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res, 2005; 37: 505-509","DOI":"10.1055\/s-2005-870318"},{"key":"61","doi-asserted-by":"crossref","unstructured":"63) Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA: Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care, 2005; 28: 2181-2186","DOI":"10.2337\/diacare.28.9.2181"},{"key":"62","doi-asserted-by":"crossref","unstructured":"64) von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA: Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care, 2004; 27: 2925-2929","DOI":"10.2337\/diacare.27.12.2925"},{"key":"63","doi-asserted-by":"crossref","unstructured":"65) Itakura H, Murase T, Takaku F: Hepatic triglyceride lipase activity in plasma of patients with fatty liver, after treatment with heparin. Clin Chem, 1983; 29: 726-727","DOI":"10.1093\/clinchem\/29.4.726"},{"key":"64","doi-asserted-by":"crossref","unstructured":"66) Osono Y, Nakajima K, Hata Y: Hypertriglyceridemia and fatty liver: clinical diagnosis of fatty liver and lipoprotein profiles in hypertriglyceridemic patients with fatty liver. J Atheroscler Thromb, 1995; 2 Suppl 1: S47-52","DOI":"10.5551\/jat1994.2.Supplement1_S47"},{"key":"65","doi-asserted-by":"crossref","unstructured":"67) Lucero D, Zago V, L\u00f3pez GI, Graffigna M, L\u00f3pez GH, Fainboim H, Miksztowicz V, Rosso LG, Belli S, Levalle O, Berg G, Brites F, Wikinski R, Schreier L: Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome? Clin Chim Acta, 2011; 412: 587-592","DOI":"10.1016\/j.cca.2010.12.012"},{"key":"66","doi-asserted-by":"crossref","unstructured":"68) Chiu HK, Qian K, Ogimoto K, Morton GJ, Wisse BE, Agrawal N, McDonald TO, Schwartz MW, Dichek HL: Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis. Endocrinology, 2010; 151: 993-1001","DOI":"10.1210\/en.2009-1100"},{"key":"67","doi-asserted-by":"crossref","unstructured":"69) Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA: Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care, 2009; 32: 741-750","DOI":"10.2337\/dc08-1870"},{"key":"68","doi-asserted-by":"crossref","unstructured":"70) Miksztowicz V, Lucero D, Zago V, Cacciagi\u00fa L, Lopez G, Gonzalez Ballerga E, Sord\u00e1 J, Fassio E, Schreier L, Berg G: Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance. Diabetes Metab Res Rev, 2012; 28: 535-541","DOI":"10.1002\/dmrr.2312"},{"key":"69","doi-asserted-by":"crossref","unstructured":"71) Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT, Boekholdt SM: Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol, 2006; 26: 637-642","DOI":"10.1161\/01.ATV.0000201038.47949.56"},{"key":"70","doi-asserted-by":"crossref","unstructured":"72) Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R, Ueda K, Inaba T, Minekura H, Kohama T, Furukawa H: ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem, 2002; 277: 33742-33748","DOI":"10.1074\/jbc.M203215200"},{"key":"71","doi-asserted-by":"crossref","unstructured":"73) Fujimoto K, Koishi R, Shimizugawa T, Ando Y: Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim, 2006; 55: 27-34","DOI":"10.1538\/expanim.55.27"},{"key":"72","doi-asserted-by":"crossref","unstructured":"74) Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y, Koishi R, Furukawa H: Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem, 2003; 278: 41804-41809","DOI":"10.1074\/jbc.M302861200"},{"key":"73","doi-asserted-by":"crossref","unstructured":"75) Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, Shimizugawa T, Ando Y, Koishi R, Kohama T, Sakai N, Kotani K, Komuro R, Ishida T, Hirata K, Yamashita S, Furukawa H, Shimomura I: Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol, 2007; 27: 366-372","DOI":"10.1161\/01.ATV.0000252827.51626.89"},{"key":"74","doi-asserted-by":"crossref","unstructured":"76) Moon HD, Nakajima K, Kamiyama K, Takanashi K, Sakurabayashi I, Nagamine T: Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemics. Clin Chim Acta, 2008; 398: 93-104","DOI":"10.1016\/j.cca.2008.08.021"},{"key":"75","doi-asserted-by":"crossref","unstructured":"77) Sun L, Ishida T, Miyashita K, Kinoshita N, Mori K, Yasuda T, Toh R, Nakajima K, Imamura S, Hirata K: Plasma activity of endothelial lipase impacts high-density lipoprotein metabolism and coronary risk factors in humans. J Atheroscler Thromb, 2014; 21: 313-321","DOI":"10.5551\/jat.20131"},{"key":"76","doi-asserted-by":"crossref","unstructured":"78) Badellino KO, Wolfe ML, Reilly MP, Rader DJ: Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med, 2006; 3: e22","DOI":"10.1371\/journal.pmed.0030022"},{"key":"77","doi-asserted-by":"crossref","unstructured":"79) Lamarche B, Paradis ME: Endothelial lipase and the metabolic syndrome. Curr Opin Lipidol, 2007; 18: 298-303","DOI":"10.1097\/MOL.0b013e328133857f"},{"key":"78","doi-asserted-by":"crossref","unstructured":"80) Badellino KO, Wolfe ML, Reilly MP, Rader DJ: Endothelial lipase is increased in vivo by inflammation in humans. Circulation, 2008; 117: 678-685","DOI":"10.1161\/CIRCULATIONAHA.107.707349"},{"key":"79","doi-asserted-by":"crossref","unstructured":"81) Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA: Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care, 2005; 28: 2181-2186","DOI":"10.2337\/diacare.28.9.2181"},{"key":"80","doi-asserted-by":"crossref","unstructured":"82) Kobayashi J, Kusunoki M, Murase Y, Kawashiri M, Higashikata T, Miwa K, Katsuda S, Takata M, Asano A, Nohara A, Inazu A, Mabuchi H: Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res, 2005; 37: 505-509","DOI":"10.1055\/s-2005-870318"},{"key":"81","doi-asserted-by":"crossref","unstructured":"83) Lewis GF, Murdoch S, Uffelman K, Naples M, Szeto L, Albers A, Adeli K, Brunzell JD: Hepatic lipase mRNA, protein, and plasmaenzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone. Diabetes, 2004; 53: 2893-2900","DOI":"10.2337\/diabetes.53.11.2893"},{"key":"82","doi-asserted-by":"crossref","unstructured":"84) Sibley SD, Palmer JP, Hirsch IB, Brunzell JD: Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab, 2003; 88: 3379-3384","DOI":"10.1210\/jc.2002-021693"},{"key":"83","doi-asserted-by":"crossref","unstructured":"85) Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD: Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res, 2003; 44: 1279-1286","DOI":"10.1194\/jlr.R200017-JLR200"},{"key":"84","doi-asserted-by":"crossref","unstructured":"86) Ruel IL, Lamarche B, Mauger JF, Badellino KO, Cohn JS, Marcil M, Couture P: Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency. Arterioscler Thromb Vasc Biol, 2005; 25: 2600-2607","DOI":"10.1161\/01.ATV.0000190700.76493.bb"},{"key":"85","doi-asserted-by":"crossref","unstructured":"87) Al Riyami N, Al-Ali AM, Al-Sarraf AJ, Hill J, Sachs-Barrable K, Hegele R, Wasan KM, Frohlich J: Hepatic lipase deficiency in a Middle-Eastern-Arabic male. BMJ Case Rep, 2010 Nov 12; 2010. pii: bcr1220092589","DOI":"10.1136\/bcr.12.2009.2589"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/22\/10\/22_31617\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T10:32:37Z","timestamp":1691836357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/22\/10\/22_31617\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.31617","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}